Annovis Bio Inc (ANVS) — Strategic Asset Allocation Index
Annovis Bio Inc (ANVS) has a Strategic Asset Allocation Index of 3.7% as of September 2013. Strategic assets (PP&E of $63.58K plus long-term investments of $-) total $63.58K, measured against net assets of $1.71 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Annovis Bio Inc Strategic Asset Allocation Index (2009–2012)
This chart shows how Annovis Bio Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2009 to 2012. As of September 2013, the index stands at 3.7%, representing strategic assets of $63.58K against net assets of $1.71 Million USD. Explore how efficiently does Annovis Bio Inc generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Annovis Bio Inc (2009–2012)
The table below presents the year-by-year Strategic Asset Allocation Index for Annovis Bio Inc from 2009 to 2012, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Annovis Bio Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2012 | 2.4% | $65.09K | $65.09K | $- | $2.66 Million | ▼ -2.1 pp |
| 2011 | 4.6% | $636.79K | $636.79K | $- | $13.93 Million | ▼ -0.2 pp |
| 2010 | 4.7% | $780.12K | $780.12K | $- | $16.49 Million | ▲ +3.3 pp |
| 2009 | 1.4% | $21.02K | $21.02K | $- | $1.48 Million | — |